Primary study · included by 1 review

Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up.

Tartaroti 2020 · Tartaroti Natália Caroline, Marques Márcia Martins, Naclério-Homem Maria da Graça, et al. · Photodiagnosis and photodynamic therapy · 2020

Included by

Antibiotic Prophylaxis and Postoperative Therapy in Tooth Extractions for Patients at Risk of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Scoping Review.

Non-Cochrane · intervention · 2025 · cited as Tartaroti 2020 · Table 1; reference 42; Figure 4

Outcome this study informs	Pooled effect	Evidence	Certainty
MRONJ incidence (MRONJ/bone exposure cases) High-dose bone-modifying agent therapy vs Low-dose bone-modifying agent therapy	OR 3.26 [1.74, 6.10]	16 studies · 1187 participants	GRADE not reported
MRONJ incidence (MRONJ/bone exposure cases) High-dose bone-modifying agent therapy vs Low-dose bone-modifying agent therapy	OR 33.5 [6.3, 177.8]	32 studies	GRADE not reported
MRONJ incidence (MRONJ/bone exposure cases) High-dose bone-modifying agent therapy vs Low-dose bone-modifying agent therapy	OR 2.82 [1.46, 5.43]	16 studies · 1187 participants	GRADE not reported

1 including review in total.